CN102725638A - 生物化学血清标志物 - Google Patents
生物化学血清标志物 Download PDFInfo
- Publication number
- CN102725638A CN102725638A CN2010800540207A CN201080054020A CN102725638A CN 102725638 A CN102725638 A CN 102725638A CN 2010800540207 A CN2010800540207 A CN 2010800540207A CN 201080054020 A CN201080054020 A CN 201080054020A CN 102725638 A CN102725638 A CN 102725638A
- Authority
- CN
- China
- Prior art keywords
- bag3
- antibody
- solubility
- albumen
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Abstract
Description
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A002154A IT1397083B1 (it) | 2009-12-04 | 2009-12-04 | Marcatore biochimico serico |
ITMI2009A002154 | 2009-12-04 | ||
PCT/EP2010/068836 WO2011067377A1 (en) | 2009-12-04 | 2010-12-03 | Biochemical serum marker |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102725638A true CN102725638A (zh) | 2012-10-10 |
CN102725638B CN102725638B (zh) | 2014-08-20 |
Family
ID=42244209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080054020.7A Active CN102725638B (zh) | 2009-12-04 | 2010-12-03 | 生物化学血清标志物 |
Country Status (14)
Country | Link |
---|---|
US (1) | US8673585B2 (zh) |
EP (1) | EP2507635B1 (zh) |
JP (1) | JP5677450B2 (zh) |
KR (1) | KR101851392B1 (zh) |
CN (1) | CN102725638B (zh) |
AU (1) | AU2010326600B2 (zh) |
BR (1) | BR112012013418B1 (zh) |
CA (1) | CA2782544C (zh) |
DK (1) | DK2507635T3 (zh) |
ES (1) | ES2530734T3 (zh) |
HK (1) | HK1176678A1 (zh) |
IT (1) | IT1397083B1 (zh) |
PT (1) | PT2507635E (zh) |
WO (1) | WO2011067377A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1397083B1 (it) | 2009-12-04 | 2012-12-28 | Biouniversa Srl | Marcatore biochimico serico |
KR101436684B1 (ko) | 2012-03-09 | 2014-09-01 | 가톨릭대학교 산학협력단 | 저산소성 허혈 예방 또는 치료용 조성물 |
ITMI20130403A1 (it) | 2013-03-18 | 2014-09-19 | Biouniversa Srl | Anticorpi anti-bag3 per uso terapeutico |
EP2676966A1 (en) | 2012-06-19 | 2013-12-25 | Biouniversa S.r.l. | BAG3 as biochemical serum and tissue marker |
ITMI20131351A1 (it) | 2013-08-07 | 2015-02-08 | Biouniversa Srl | Molecole leganti il recettore di bag3 per uso terapeutico. |
ITUB20155097A1 (it) | 2015-11-05 | 2017-05-05 | Biouniversa Srl | Anticorpi umanizzati anti-BAG3 |
IT201600069391A1 (it) * | 2016-07-04 | 2016-10-04 | Univ Degli Studi Di Salerno | Uso della proteina bag3 e suoi frammenti peptidici per il controllo dell’omeostasi vascolare |
IT201600111877A1 (it) | 2016-11-07 | 2018-05-07 | Biouniversa Srl | Anti-BAG3 antibodies in combination with inhibitors of immune check-point for therapeutic use |
JP6873460B2 (ja) * | 2017-01-12 | 2021-05-19 | テオリアサイエンス株式会社 | 被検者が膵臓癌に罹患している可能性を試験する方法 |
EP3658582A1 (en) | 2017-07-28 | 2020-06-03 | Intrepida Bio, Inc. | Anti-bag3 antibodies as therapeutic reagent in cardiovascular diseases |
IT201700113648A1 (it) * | 2017-10-10 | 2019-04-10 | Biouniversa Srl | Anti-BAG3 antibodies as therapeutic reagent in cardiovascular diseases |
KR20200133240A (ko) * | 2018-03-16 | 2020-11-26 | 브리스톨-마이어스 스큅 컴퍼니 | 단백질 생산 동안의 대사 효소 활성 및 디술피드 결합 환원 |
WO2021140173A1 (en) | 2020-01-10 | 2021-07-15 | Biouniversa S.R.L. | Methods and uses for treating fibrotic solid tumors with bags inhibitors |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1323733A1 (en) * | 2001-12-28 | 2003-07-02 | Arturo Leone | BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
CN101358976A (zh) * | 2008-04-28 | 2009-02-04 | 北京华大吉比爱生物技术有限公司 | 检测六项肿瘤标志物的微阵列-酶联免疫检测试剂盒 |
CN101505791A (zh) * | 2006-08-14 | 2009-08-12 | 株式会社未来创药研究所 | 使用抗桥粒芯蛋白3抗体的癌症的诊断和治疗 |
CN101594883A (zh) * | 2006-10-12 | 2009-12-02 | 株式会社未来创药研究所 | 使用抗ereg抗体的癌症的诊断和治疗 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5789500A (en) * | 1999-07-09 | 2001-01-30 | Burnham Institute, The | A method for determining the prognosis of cancer patients by measuring levels ofbag expression |
JP2005229874A (ja) * | 2004-02-18 | 2005-09-02 | Institute Of Physical & Chemical Research | Bag3ドメインポリペプチド及びその用途 |
JP5171812B2 (ja) * | 2006-04-27 | 2013-03-27 | ユニベルシテ ドゥ モントリオール | 移植片対宿主病のリスクの評価および低減 |
IT1397083B1 (it) | 2009-12-04 | 2012-12-28 | Biouniversa Srl | Marcatore biochimico serico |
-
2009
- 2009-12-04 IT ITMI2009A002154A patent/IT1397083B1/it active
-
2010
- 2010-12-03 US US13/513,766 patent/US8673585B2/en active Active
- 2010-12-03 DK DK10805698.7T patent/DK2507635T3/en active
- 2010-12-03 PT PT108056987T patent/PT2507635E/pt unknown
- 2010-12-03 ES ES10805698T patent/ES2530734T3/es active Active
- 2010-12-03 CA CA2782544A patent/CA2782544C/en active Active
- 2010-12-03 BR BR112012013418-3A patent/BR112012013418B1/pt active IP Right Grant
- 2010-12-03 CN CN201080054020.7A patent/CN102725638B/zh active Active
- 2010-12-03 AU AU2010326600A patent/AU2010326600B2/en active Active
- 2010-12-03 EP EP10805698.7A patent/EP2507635B1/en active Active
- 2010-12-03 KR KR1020127017249A patent/KR101851392B1/ko active IP Right Grant
- 2010-12-03 WO PCT/EP2010/068836 patent/WO2011067377A1/en active Application Filing
- 2010-12-03 JP JP2012541519A patent/JP5677450B2/ja active Active
-
2013
- 2013-04-01 HK HK13103973.0A patent/HK1176678A1/zh unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1323733A1 (en) * | 2001-12-28 | 2003-07-02 | Arturo Leone | BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
WO2003055908A2 (en) * | 2001-12-28 | 2003-07-10 | Arturo Leone | Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
CN101505791A (zh) * | 2006-08-14 | 2009-08-12 | 株式会社未来创药研究所 | 使用抗桥粒芯蛋白3抗体的癌症的诊断和治疗 |
CN101594883A (zh) * | 2006-10-12 | 2009-12-02 | 株式会社未来创药研究所 | 使用抗ereg抗体的癌症的诊断和治疗 |
CN101358976A (zh) * | 2008-04-28 | 2009-02-04 | 北京华大吉比爱生物技术有限公司 | 检测六项肿瘤标志物的微阵列-酶联免疫检测试剂盒 |
Non-Patent Citations (4)
Title |
---|
MARTIN GAMERDINGER ET AL: "Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3", 《EUROPEAN MOLECULAR BIOLOGY ORGANIZATION》, vol. 28, 19 February 2009 (2009-02-19), pages 889 - 901 * |
MASAHIRO IWASAKI ET AL: "BAG3 Regulates Motility and Adhesion of Epithelial Cancer Cells", 《CANCER RESEARCH》, vol. 67, 31 December 2007 (2007-12-31), pages 10252 - 10259 * |
SERENA CARRA ET AL: "HspB8 and Bag3 A new chaperone complex targeting misfolded proteins to macroautophagy", 《AUTOPHAGY》, vol. 4, no. 2, 16 February 2008 (2008-02-16), pages 237 - 239 * |
高红等: "细胞凋亡相关基因Bcl-2和NF-kB在甲状腺癌中的表达及意义", 《中国误诊学杂志》, vol. 5, no. 18, 31 December 2005 (2005-12-31), pages 3407 - 3408 * |
Also Published As
Publication number | Publication date |
---|---|
KR20120121391A (ko) | 2012-11-05 |
EP2507635A1 (en) | 2012-10-10 |
CA2782544A1 (en) | 2011-06-09 |
JP2013513101A (ja) | 2013-04-18 |
BR112012013418A2 (pt) | 2017-12-12 |
ES2530734T3 (es) | 2015-03-05 |
DK2507635T3 (en) | 2015-02-09 |
WO2011067377A1 (en) | 2011-06-09 |
EP2507635B1 (en) | 2014-11-19 |
US20120244561A1 (en) | 2012-09-27 |
IT1397083B1 (it) | 2012-12-28 |
JP5677450B2 (ja) | 2015-02-25 |
US8673585B2 (en) | 2014-03-18 |
AU2010326600A1 (en) | 2012-07-19 |
CN102725638B (zh) | 2014-08-20 |
KR101851392B1 (ko) | 2018-04-23 |
ITMI20092154A1 (it) | 2011-06-05 |
CA2782544C (en) | 2019-08-06 |
BR112012013418B1 (pt) | 2019-11-26 |
HK1176678A1 (zh) | 2013-08-02 |
PT2507635E (pt) | 2015-02-24 |
AU2010326600B2 (en) | 2016-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102725638B (zh) | 生物化学血清标志物 | |
Petridou et al. | Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies | |
Krawczyk et al. | Usefulness of the Triglycerides to High-Density Lipoprotein Cholesterol ratio (TG/HDL-C) in prediction of metabolic syndrome in Polish obese children and adolescents | |
WO2015089575A1 (en) | Method of diagnosis and treatment | |
CN106461681B (zh) | 用于诊断血管疾病的生物标志物及其用途 | |
Lian et al. | CACYBP enhances cytoplasmic retention of P27Kip1 to promote hepatocellular carcinoma progression in the absence of RNF41 mediated degradation | |
KR102266302B1 (ko) | 심혈관 질환 또는 문제 위험 예측용 방법 및 키트 | |
AU2013279604B2 (en) | BAG3 as biochemical serum and tissue marker | |
Lukic et al. | An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis | |
Du et al. | Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer | |
WO2019033866A1 (zh) | 肿瘤血液标志物及其应用 | |
Park et al. | Proteomic analysis of urothelium of rats with detrusor overactivity induced by bladder outlet obstruction | |
EP2757376A9 (en) | Molecular marker for early indentification of pleural mesothelioma patients, and expression analysis method for same | |
KR102441107B1 (ko) | 데옥시하이푸신·신타제 유전자를 지표로서 사용하는 동맥 경화 및 암의 검출 방법 | |
CN108982868A (zh) | 核体蛋白sp110及含有该蛋白的试剂盒在制备酒精性心肌病早期诊断试剂中的应用 | |
WO2008112424A1 (en) | Assessing heart failure | |
WO2016143805A1 (ja) | 膀胱がんの検出方法 | |
Shen et al. | Analysis of clinically relevant factors for pulmonary hypertension in maintenance hemodialysis patients | |
CN107543929A (zh) | 基于蛋白标志物hsp90ab1诊断肺癌患者的试剂盒 | |
US9182413B2 (en) | Methods and devices for diagnosing cardiac disorders | |
CN115976196A (zh) | ErbB3作为肺动脉高压生物标志物和治疗靶点的应用 | |
KR20200135994A (ko) | 심장 근육 손상의 진단 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1176678 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1176678 Country of ref document: HK |
|
CP02 | Change in the address of a patent holder |
Address after: Italy Patentee after: BIOUNIVERSA S.R.L. Address before: Italy Patentee before: BIOUNIVERSA S.R.L. |
|
CP02 | Change in the address of a patent holder |